{"context":{"query":">>hgnc>>gwas","source_dataset":"hgnc","target_dataset":"gwas"},"stats":{"queried":1,"total":50,"mapped":1},"pagination":{"has_next":false},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"HGNC:11998","source":"HGNC:11998|tumor protein p53","targets":["GCST001250_1|Basal cell carcinoma|TP53|17|2.000000e-20","GCST002331_9|Basal cell carcinoma|TP53|17|4.000000e-22","GCST002568_2|Esophageal squamous cell carcinoma|ATP1B2|17|3.000000e-13","GCST002842_7|Basal cell carcinoma|TP53|17|1.000000e-20","GCST002925_8|Sex hormone levels|TP53|17|1.000000e-15","GCST003726_18|Basal cell carcinoma|TP53|17|2.000000e-10","GCST004278_22|Pulse pressure|TP53|17|2.000000e-10","GCST004278_40|Pulse pressure|SHBG|17|2.000000e-07","GCST004280_49|Diastolic blood pressure|SLC2A4|17|1.000000e-13","GCST004347_18|Glioma|TP53|17|9.000000e-38","GCST004348_4|Non-glioblastoma glioma|TP53|17|5.000000e-27","GCST004349_13|Glioblastoma|TP53|17|5.000000e-29","GCST004510_7|Sporadic neuroblastoma|TP53|17|1.000000e-08","GCST004630_260|Mean corpuscular hemoglobin|TP53|17|6.000000e-09","GCST005931_4|Glioma|TP53|17|3.000000e-17","GCST005931_5|Glioma|TP53|17|2.000000e-12","GCST005932_1|Glioblastoma|TP53|17|2.000000e-09","GCST005932_14|Glioblastoma|TP53|17|1.000000e-14","GCST005933_4|Non-glioblastoma glioma|TP53|17|1.000000e-10","GCST005933_5|Non-glioblastoma glioma|TP53|17|4.000000e-08","GCST006462_47|Uterine fibroids|TP53|17|4.000000e-37","GCST006480_12|Glioblastoma (age-stratified)|TP53|17|9.000000e-16","GCST006480_19|Glioblastoma (age-stratified)|TP53|17|3.000000e-08","GCST006480_6|Glioblastoma (age-stratified)|TP53|17|4.000000e-13","GCST007094_180|Diastolic blood pressure|TP53|17|1.000000e-08","GCST007096_39|Pulse pressure|TP53|17|4.000000e-13","GCST007268_21|Diastolic blood pressure|TP53|17|3.000000e-15","GCST007269_171|Pulse pressure|TP53|17|8.000000e-23","GCST008362_2|Birth weight|TP53|17|2.000000e-11","GCST008423_10|Uterine fibroids|TP53|17|3.000000e-33","GCST008870_8|Keratinocyte cancer (MTAG)|TP53|17|4.000000e-25","GCST008871_42|Basal cell carcinoma|TP53|17|6.000000e-33","GCST009066_44|Mosaic loss of chromosome Y (Y chromosome dosage)|TP53|17|1.000000e-08","GCST009158_4|Uterine fibroids|TP53|17|7.000000e-31","GCST009375_3|Mosaic loss of chromosome Y (Y chromosome dosage)|TP53|17|3.000000e-28","GCST009503_1|Cancer|TP53|17|8.000000e-06","GCST010245_90|LDL cholesterol levels|TP53|17|2.000000e-09","GCST010303_20|Nevus count or cutaneous melanoma|TP53|17|3.000000e-12","GCST010304_28|Cutaneous malignant melanoma|TP53|17|1.000000e-09","GCST010304_37|Cutaneous malignant melanoma|TP53|17|3.000000e-10","GCST010703_12|Brain morphology (MOSTest)|SHBG|17|3.000000e-09","GCST90000025_555|Appendicular lean mass|TP53|17|5.000000e-56","GCST90002390_120|Mean corpuscular hemoglobin|TP53|17|1.000000e-22","GCST90002392_490|Mean corpuscular volume|TP53|17|1.000000e-20","GCST90002394_312|Monocyte percentage of white cells|TP53|17|3.000000e-09","GCST90002396_317|Mean reticulocyte volume|TP53|17|2.000000e-12","GCST90002397_710|Mean spheric corpuscular volume|TP53|17|2.000000e-22","GCST90002403_320|Red blood cell count|TP53|17|3.000000e-21","GCST90013410_7|Basal cell carcinoma|TP53|17|8.000000e-27","GCST90014033_65|Haemorrhoidal disease|TP53|17|5.000000e-10"]}]}